RivoceranibVarious toxicities: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1859卷 / 1期

关键词：

D O I：

10.1007/s40278-021-97428-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：332 / 332

相关论文

共 50 条

[31] Carboplatin/etoposide/rivoceranibVarious toxicities: case report
Reactions Weekly, 2018, 1717 (1) : 80 - 80
[32] RivoceranibVarious toxicities and development of resistance: case report
Reactions Weekly, 2019, 1737 (1) : 258 - 258
[33] Programmed-cell-death-1-receptor-antagonists/rivoceranibVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1833 (1) : 331 - 331
[34] Osimertinib/rivoceranibVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1871 (1) : 336 - 336
[35] AntineoplasticsVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1866 (1) : 57 - 57
[36] AzathioprineVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1833 (1) : 89 - 89
[37] DeferasiroxMultiple toxicities: 4 case reports
Reactions Weekly, 2022, 1893 (1) : 116 - 116
[38] AdalimumabVarious toxicities: 4 case reports
Reactions Weekly, 2023, 1977 (1) : 17 - 17
[39] AntineoplasticsVarious toxicities: 4 case reports
Reactions Weekly, 2023, 1962 (1) : 54 - 54
[40] CelecoxibVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1697 (1) : 109 - 109

← 1 2 3 4 5 →